| Treatment | Diabetic Macular Edema |
| Packaging Type | Single-dose Vial |
| Strength | 6 mg/0.05 mL |
| Composition | Faricimab |
| Dosage Form | Injection |
| Shelf life | 24 Months |
Minimum order quantity: 10 Box
Vabysmo faricimab-svoa 6mg Injection
Product Intoduction Vabysmo faricimab-svoa 6mg Injection is a prescription-only ophthalmic medicine used for the treatment of serious retinal diseases that can lead to vision loss. It is administered as an intravitreal injection, meaning it is injected directly into the vitreous humor of the eye by a qualified ophthalmologist under sterile conditions.
Faricimab-svoa is a bispecific monoclonal antibody, designed using advanced biotechnology to target two key pathways involved in retinal disease progression. Unlike traditional anti-VEGF therapies that block only vascular endothelial growth factor, Faricimab-svoa simultaneously inhibits VEGF-A and angiopoietin-2. This dual-action mechanism helps reduce abnormal blood vessel growth, leakage, and inflammation while also improving blood vessel stability in the retina.
The medicine is primarily indicated for conditions such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. These conditions are commonly associated with diabetes and aging and are major causes of visual impairment and blindness if left untreated.
Faricimab-svoa is supplied as a 6 mg single-dose injection and must be administered only in a clinical setting. The dosing schedule varies depending on the disease being treated and the patient’s response, and it may allow for extended treatment intervals compared to some other retinal therapies.
Uses of faricimab InjectionWet Age-Related Macular DegenerationDiabetic Macular EdemaDiabetic Retinopathy
Benefits of faricimab InjectionHelps reduce swelling and fluid leakage in the retinaSlows down vision lossCan improve or stabilize visionWorks on two disease pathways, which may allow longer intervals between injections for some patients
Side effects of faricimab InjectionEye pain or discomfortRedness in the eyeFeeling of something in the eyeBlurred visionIncreased eye pressure
How to use faricimab InjectionFaricimab-svoa is not self-administeredIt is injected directly into the eye by an ophthalmologistThe dosing schedule depends on your eye condition and response to treatment
How faricimab Injection works VEGF-A → reduces abnormal blood vessel growth and leakageAngiopoietin-2 (Ang-2) → helps stabilize blood vessels
Safety advice Alcohol Moderate consumption is generally considered safe, but follow your doctor’s advice.
Pregnancy Should be used only if clearly neededInform your doctor if you are pregnant or planning pregnancy
Breast feeding Use with cautionDoctor will weigh benefits vs risks
Driving You may have temporary blurred vision after the injectionDo not drive until your vision is completely clear
Kidney Generally safe for patients with kidney disease